Skip to main content

Year: 2023

Notice Regarding the Increase of Authorized Capital for Orkela Uab

With this notice, we inform you that in 2023 October 9 The sole shareholder of ORKELA UAB (hereinafter – the Company), the closed-end real estate investment fund for informed investors Lords LB Special Fund IV (fund code I032; hereinafter – the Shareholder), has made a decision to increase the Company’s authorized capital from EUR 1,000,000 to EUR 1,050,000 by issuing 2,000 ordinary registered shares The company’s shares, each of which has a nominal value of EUR 25. The issue price of all the Company’s new shares is equal to EUR 3,500,000, of which: the sum of the nominal values of the new shares in the amount of EUR 50,000 and the share premium in the amount of EUR 3,450,000. The company’s newly registered authorized capital and updated articles of association were registered in the Legal Entities Register...

Continue reading

Bleeding Disorders Testing Market Size to Surpass USD 161.9 Million by 2030, at a CAGR of 7.9%

As per the report by Fortune Business Insights, The Bleeding Disorders Testing Market size is projected to reach USD 161.9 Million by 2030, at a CAGR of 7.9% during the forecast period.Bleeding Disorders Testing MarketBleeding Disorder Testing Market (2023-2030)Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — The global bleeding disorders testing market size was valued at USD 88.5 million in 2022, and it is set to expand from USD 94.9 million in 2023 to USD 161.9 million by 2030, exhibiting a CAGR of 7.9% over the estimated period. The market growth is being driven by the surging prevalence of bleeding disorders such as Von Willebrand disease, haemophilia A, haemophilia B, and others. This information is provided by Fortune Business Insights™ in its research report, titled “Bleeding Disorders Testing Market, 2023-2030”. Key...

Continue reading

Hywin Files Its Fiscal Year 2023 Annual Report on Form 20-F

SHANGHAI, China, Oct. 18, 2023 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin” or the “Company”) (NASDAQ: HYW), a leading independent wealth management service provider in China, today announced that it has filed its annual report containing its audited consolidated financial statements for the fiscal year ended June 30, 2023 on Form 20-F with the Securities and Exchange Commission (the “SEC”) on October 18, 2023 Eastern Time. The annual report can be accessed on Hywin’s investor relations website at https://ir.hywinwealth.com and on the SEC’s website at http://www.sec.gov. The Company will provide hard copies of the annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to ir@hywinwealth.com. About Hywin Holdings Ltd. Hywin (NASDAQ: HYW) is a leading...

Continue reading

Europe Urinary Catheters Market Size to Surpass USD 2.32 billion by 2030, exhibiting a CAGR of 7.4%

As per the report by Fortune Business Insights, the Europe urinary catheters market size is projected to reach USD 2.32 billion by 2030, at a CAGR of 7.4% during the forecast periodEurope Urinary Catheters MarketEurope Urinary Catheters Market (2023-2030)Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — The Europe urinary catheters market size touched USD 1.32 billion in 2022 and is predicted to reach USD 1.41 billion in 2023 and it is anticipated to touch USD 2.32 billion by 2030, recording a CAGR of 7.4% over the projected period. According to various regional studies, aging increases the chances of developing different bladder-associated disorders, such as urine leakage, benign prostate hyperplasia, urine retention, and others. Hence, the growing geriatric population is accelerating the market expansion. A rise in surgical...

Continue reading

Disposable Medical Gloves Market Size to Surpass USD 24.44 Billion by 2030, at a CAGR of 15.1%

As per the report by Fortune Business Insights, The global disposable medical gloves market size was valued at USD 7.89 billion in 2022 and is expected to be worth USD 9.14 billion in 2023. The market is predicted to reach USD 24.44 billion by 2030, exhibiting a CAGR of 15.1% during the forecast period.Disposable Medical Gloves MarketForecast 2023-2030Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — Global disposable medical gloves market size was valued at USD 7.89 billion in 2022 the market is predicted to reach USD 24.44 billion by 2030 exhibiting a CAGR of 15.1% during forecast period. Growing Awareness Regarding Safety and Hygiene to Prevent Healthcare-Associated Infections (HAI) to Foster Market Growth Disposable medical gloves prevent infection transmission and are used extensively during surgeries. The growing awareness...

Continue reading

Normal Saline for Parenteral Use Market Size to Surpass USD 5.48 Billion by 2030, exhibiting a CAGR of 6.9%

As per the report by Fortune Business Insights, the global normal saline for parenteral use market size is projected to reach USD 5.48 billion in 2030, at a CAGR of 6.9% during the forecast period, 2023-2030Normal Saline for Parenteral Use MarketNormal Saline for Parenteral Use Market Forecast (2023-2030)Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — The normal saline for parenteral use market size expected to expand from USD 3.44 billion in 2023 to USD 5.48 billion by 2030, exhibiting a CAGR of 6.9% over the study period. Expansion can be credited to growing government recommendations and regulations for deployment of 0.9% sodium chloride and fluid resuscitation in severe conditions. Fortune Business Insights™ provides this information in its research report titled “Normal Saline for Parenteral Use Market, 2023-2030”. Key...

Continue reading

Skincare Market to Surpass 204.61 Billion by 2030 Drives Due to Rising Beauty Awareness

SkyQuest projects that the skincare market will attain a USD 204.61 billion value by 2030, with a CAGR of 4.6% over the forecast period (2023-2030). Increasing consciousness about skin health and appearance drives the global skincare market. Consumers prioritize effective products for various skin types, fueling demand for specialized solutions and natural ingredients. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, easy accessibility through e-commerce platforms and digital marketing strategies significantly boosts the skincare market growth. Online reviews, tutorials, and personalized recommendations influence consumer choices, fostering a global market driven by convenience and virtual engagement. Browse In-Depth TOC on the “Skincare Market”  Pages – 157 Tables – 117 Figures –...

Continue reading

Track and Trace Solution Market Size to Surpass USD 20.10 billion by 2030, exhibiting a CAGR of 17.7%

As per the report by Fortune Business Insights, the global Track and Trace Solution Market size is projected to reach USD 20.10 billion by 2030, at a CAGR of 17.7% during the forecast period.Track and Trace Solution MarketForecast, 2023– 2030Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global track and trace solution market size was valued at USD 5.52 billion in 2022 and is projected to reach USD 20.10 billion by 2030, exhibiting a CAGR of 17.7% during the forecast period. Increasing Sales of Counterfeit Products to Facilitate Market Elevation. This information is provided by Fortune Business Insights, in its report titled, Track and Trace Solution Market Forecast, 2023-2030. The rising sales of counterfeit and fake products and growing adoption of blockchain technology in supply...

Continue reading

Click, Shop, Savor: Ultrasound Image Analysis Software Market Set to Soar Past USD 6.3 Billion by 2030

The global Ultrasound Image Analysis Software market size is expected to reach USD 6.3 billion by 2030 and exhibit a CAGR of 7.7% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for non-invasive diagnostic techniques, advancements in ultrasound imaging technology, rising prevalence of chronic diseases and conditions, technological advancements in ultrasound image analysis software, increasing focus on early disease detection and prevention, are fueling the Market’s growth. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Ultrasound Image Analysis Software market, growing demand for AI-powered image analysis software, increasing use of cloud-based platforms for data storage and analysis, emergence of portable...

Continue reading

G1 Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 1, 2023

RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate update for the third quarter 2023 on Wednesday November 1, 2023, at 8:30 a.m. ET. Please note that there is a new process to access the call via telephone. To register and receive a dial in number and unique PIN to access the live conference call, please follow this link to register online. While not required, it is recommended that you join 10 minutes prior to the start of the event. A live and archived webcast will be available on the Events & Presentations page of the company’s website: www.g1therapeutics.com. The webcast will be archived on the same page for 90 days following the event. About G1 TherapeuticsG1...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.